Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Individual differences in tolerated time during head-up tilt testing between norepinephrine reuptake transporter (NET) inhibition and placebo treatment. In subjects who tolerated the full duration of the tilt study, both on placebo and during NET inhibition, the difference is 0. The solid vertical lines indicate the mean value and the boundaries of the 95% confidence interval.
|
